Pharma sector dangerously ‘dragging on Draghi’: Renew MEPs, experts

EU PERSPECTIVES - One year after Mario Draghi's competitiveness blueprint, the pharmaceutical sector sits at the back of the scoreboard. None of the nine recommended measures have been delivered. MEP Stine Bosse (Renew/DNK) warns against "halfway" reforms, even if that means resorting to an omnibus fix. João Cotrim de Figueiredo, Portuguese vice-president of the same faction, echoed the urgency: "Dragging on Draghi is dangerous." Read more

Pharma sector has not paid much attention to Mario Draghi's recommendations so far / Photo: Pixabay